DNB Carnegie: ALZ-101 enters Phase II start-up as Alzinova raises capital
Date: 2026-09-11
Alzinova has initiated operational preparations for the global Phase II study of ALZ-101, and also announced a SEK51m rights issue to fund the next stage.